Fig. 8From: RBP7 functions as a tumor suppressor in HR + breast cancer by inhibiting the AKT/SREBP1 pathway and reducing fatty acidRBP7 expression was related to T-stage and Ki67 score. a The association between clinicopathological features and RBP7 mRNA expression levels in HR + BC patients from TCGA. ( *P < 0.05) b Typical images of RBP7 immunohistochemical staining of HR + BC tissues with different T-stages and Ki67 scores from the tissue microarrayBack to article page